Pio Conti
#166,503
Most Influential Person Now
Researcher ORCID ID = 0000-0002-9475-4924
Pio Conti's AcademicInfluence.com Rankings
Pio Conticomputer-science Degrees
Computer Science
#10039
World Rank
#10532
Historical Rank
Computational Linguistics
#2514
World Rank
#2539
Historical Rank
Machine Learning
#4557
World Rank
#4608
Historical Rank
Artificial Intelligence
#4918
World Rank
#4982
Historical Rank
Download Badge
Computer Science
Pio Conti's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science University of California, Berkeley
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Pio Conti Influential?
(Suggest an Edit or Addition)Pio Conti's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. (2020) (962)
- Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation. (2015) (442)
- Differential release of mast cell mediators and the pathogenesis of inflammation (2007) (406)
- Mast cells: the Jekyll and Hyde of tumor growth. (2004) (352)
- Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection. (2020) (333)
- Mast cells as targets of corticotropin-releasing factor and related peptides. (2004) (309)
- IL-33 augments substance P–induced VEGF secretion from human mast cells and is increased in psoriatic skin (2010) (304)
- Neuroendocrinology of the skin (2016) (255)
- MCP-1 and RANTES are mediators of acute and chronic inflammation. (2001) (253)
- IL-10, an inflammatory/inhibitory cytokine, but not always. (2003) (245)
- Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy. (2019) (211)
- Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. (2001) (172)
- Clinical and radiographic response in a minority of patients with recurrent malignant gliomas treated with high-dose tamoxifen. (1993) (156)
- Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. (2006) (151)
- Impact of Rantes and MCP-1 chemokines on in vivo basophilic cell recruitment in rat skin injection model and their role in modifying the protein and mRNA levels for histidine decarboxylase. (1997) (137)
- Key Role of DAMP in Inflammation, Cancer, and Tissue Repair. (2016) (134)
- How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1. (2020) (129)
- Dexamethasone for COVID-19? Not so fast. (2020) (123)
- Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines (2004) (119)
- A role for Ca2+ in the effect of very low frequency electromagnetic field on the blastogenesis of human lymphocytes (1985) (110)
- Atherosclerosis: a chronic inflammatory disease mediated by mast cells (2015) (109)
- Monocyte chemotactic protein-1 provokes mast cell aggregation and [3H]5HT release. (1995) (107)
- Role of mast cells in tumor growth. (2007) (104)
- The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem. (2021) (101)
- SP and IL-33 together markedly enhance TNF synthesis and secretion from human mast cells mediated by the interaction of their receptors (2017) (96)
- Vascular Endothelial Growth Factor (VEGF), Mast Cells and Inflammation (2013) (95)
- IL-10 subfamily members: IL-19, IL-20, IL-22, IL-24 and IL-26. (2003) (88)
- A comprehensive outlook on intracerebral therapy of malignant gliomas. (2011) (88)
- Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by COVID-19: anti-inflammatory strategies. (2020) (86)
- Progression in migraine: Role of mast cells and pro‐inflammatory and anti‐inflammatory cytokines☆ (2019) (85)
- Intramuscular injection of hrRANTES causes mast cell recruitment and increased transcription of histidine decarboxylase in mice: lack of effects in genetically mast cell‐deficient W/WV mice (1998) (84)
- Targeting IL-33 in Autoimmunity and Inflammation (2015) (84)
- Treatment of chronic idiopathic urticaria and positive autologous serum skin test with cyclosporine: clinical and immunological evaluation. (2003) (80)
- IL-37 (IL-1F7) the Newest Anti-Inflammatory Cytokine Which Suppresses Immune Responses and Inflammation (2012) (76)
- The emerging role of melatonin agonists in the treatment of major depression: focus on agomelatine. (2011) (75)
- Novel therapeutic targets for autism. (2008) (71)
- Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy. (2020) (66)
- RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-β-1b (2000) (66)
- Monocyte chemotactic protein 1 (MCP-1) is a mitogen for cultured rat vascular smooth muscle cells. (1997) (66)
- Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19. (2020) (63)
- Substance P and IL-33 administered together stimulate a marked secretion of IL-1β from human mast cells, inhibited by methoxyluteolin (2018) (61)
- Impact of stress and mast cells on brain metastases (2008) (59)
- Alzheimer Patients Treated With an AchE Inhibitor Show Higher IL-4 and Lower IL-1β Levels and Expression in Peripheral Blood Mononuclear Cells (2004) (58)
- Do mast cells link obesity and asthma? (2013) (57)
- Anti-inflammatory effects of hypoxia-preconditioned human periodontal ligament cell secretome in an experimental model of multiple sclerosis: a key role of IL-37 (2017) (56)
- Effects of human interleukin-1 on natural killer cell activity: is fever a host defense mechanism for tumor killing? (1986) (56)
- Spectrum of mast cell activation disorders (2014) (56)
- Endothelial nitric oxide synthase (eNOS) expression and localization in healthy and diabetic rat hearts. (2001) (55)
- Modulation of MCP-1 and iNOS by 50-Hz sinusoidal electromagnetic field. (2006) (55)
- Anti-Chemokine Therapy for Inflammatory Diseases (2007) (54)
- IL-35, an anti-inflammatory cytokine which expands CD4+CD25+ Treg Cells. (2010) (54)
- Environmental and occupational stress and autoimmunity. (2008) (54)
- Antidepressant Therapy Can Improve Adherence to Antiretroviral Regimens Among HIV-Infected and Depressed Patients (2007) (54)
- Aluminum Impairs Rat Neural Cell Mitochondria In Vitro (2005) (54)
- Effects of resveratrol on lymphocyte proliferation and cytokine release. (2003) (53)
- Brain cytokines and neuropsychiatric disorders. (2004) (52)
- Human gingival mesenchymal stem cells pretreated with vesicular moringin nanostructures as a new therapeutic approach in a mouse model of spinal cord injury (2019) (51)
- Effects of electromagnetic fields produced by radiotelevision broadcasting stations on the immune system of women. (2001) (51)
- Modulation of autoimmunity by the latest interleukins (with special emphasis on IL-32). (2007) (49)
- Interleukin-6 and mast cells. (2002) (49)
- The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders (2020) (49)
- Inhibitory effect of quercetin on tryptase and interleukin-6 release, and histidine decarboxylase mRNA transcription by human mast cell-1 cell line (2006) (49)
- Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C virus infection and non-alcoholic fatty liver disease. (2005) (48)
- Expression of lymphocyte subpopulations, cytokine serum levels, and blood and urinary trace elements in asymptomatic atopic men exposed to an urban environment (1999) (47)
- Cysteinyl Leukotriene D4 Induced Vascular Smooth Muscle Cell Proliferation: A Possible Role in Myointimal Hyperplasia (1996) (46)
- Inducible nitric oxide synthase and heme oxygenase-1 in rat heart: direct effect of chronic exposure to hypoxia. (2003) (45)
- Important role of mast cells in multiple sclerosis. (2016) (45)
- IL-15 an immunoregulatory and anti-cancer cytokine. Recent advances. (2006) (43)
- IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra). (2020) (43)
- Activation of human natural killer cells by lipopolysaccharide and generation of interleukin-1 alpha, beta, tumour necrosis factor and interleukin-6. Effect of IL-1 receptor antagonist. (1991) (43)
- Localization of the e-NOS enzyme in endothelial cells and odontoblasts of healthy human dental pulp. (2000) (43)
- SARS-CoV-2, which induces COVID-19, causes kawasaki-like disease in children: role of pro-inflammatory and anti-inflammatory cytokines. (2020) (42)
- Nutrition and Cancer Prevention (2012) (42)
- In vitro enhanced thromboxane B2 release by polymorphonuclear leukocytes and macrophages after treatment with human recombinant interleukin 1. (1986) (42)
- Treatment with silybin‐vitamin E‐phospholipid complex in patients with hepatitis C infection (2008) (42)
- Impact of Mast Cells on the Skin (2013) (41)
- Lymphocyte subset changes in blood and gastrointestinal mucosa after oral nickel challenge in nickel‐sensitized women (2000) (41)
- The relationship between Bcl-2 gene expression and learning & memory impairment in chronic aluminum-exposed rats (2007) (40)
- T Lymphocyte Subsets and Immunoglobulins in Intracranial Tumor Patients before and after Treatment and Based on Histological Type of Tumors (2004) (40)
- Microglia and mast cells generate proinflammatory cytokines in the brain and worsen inflammatory state: Suppressor effect of IL-37. (2020) (39)
- Metabolic Syndrome and Cardiovascular Risk in HIV-Infected Patients with Lipodystrophy (2007) (39)
- COVID-19 and Multisystem Inflammatory Syndrome, or is it mast cell activation syndrome? (2020) (39)
- Differential production of RANTES and MCP-1 in synovial fluid from the inflamed human knee. (2002) (39)
- Immune Modulation by Vitamin D: Special Emphasis on Its Role in Prevention and Treatment of Cancer. (2017) (39)
- Impact of RANTES, MCP-1 and IL-8 in mast cells. (2010) (39)
- Interleukin-16 network in inflammation and allergy. (2002) (38)
- IL-32 is increased along with tryptase in lesional psoriatic skin and is up-regulated by substance P in human mast cells. (2010) (38)
- Advances in therapy with antileukotriene drugs. (2004) (37)
- Endothelial NOS expression and ischemia-reperfusion in isolated working rat heart from hypoxic and hyperoxic conditions. (2000) (37)
- The Role of Mast Cells in Alzheimer's Disease. (2016) (37)
- Chemokines in inflammatory states. (1999) (37)
- Human neutrophil elastase in RSV bronchiolitis. (2007) (36)
- Generation of TNF alpha, IFN gamma, IL-6, IL-4 and IL-10 in mouse serum from trichinellosis: effect of the anti-inflammatory compound 4-deoxypyridoxine (4-DPD). (1996) (36)
- Mitogen dose‐dependent effect of weak pulsed electromagnetic field on lymphocyte blastogenesis (1986) (36)
- Effect of Electromagnetic Fields on Two Calcium Dependent Biological Systems (1985) (35)
- Interleukin-17 and the interleukin-17 family member network. (2004) (34)
- Role of mast cells in innate and adaptive immunity. (2012) (34)
- Impact of Capsaicin on Mast Cell Inflammation (2013) (34)
- Mast cell recruitment after subcutaneous injection of RANTES in the sole of the rat paw (1998) (33)
- Decreased mitochondrial function and increased brain inflammation in bipolar disorder and other neuropsychiatric diseases. (2011) (33)
- Neurologic Soft Signs in Schizophrenic Patients Treated With Conventional and Atypical Antipsychotics (2005) (33)
- Lymphocyte subpopulations, cytokines and trace elements in asymptomatic atopic women exposed to an urban environment. (2000) (33)
- Effect of Chronic Hypoxia on Inducible Nitric Oxide Synthase Expression in Rat Myocardial Tissue (2003) (32)
- Elevated CD4+/CD25+ T cell frequency and function during acute hepatitis C presage chronic evolution (2006) (32)
- Production of MCP-1 and RANTES in bladder cancer patients after bacillus Calmette-Guerin immunotherapy (2002) (32)
- Seasonal variability of non-specific bronchial responsiveness in asthmatic patients with allergy to house dust mites. (2001) (31)
- Different effects of platinum, palladium, and rhodium salts on lymphocyte proliferation and cytokine release. (2004) (30)
- Comparison of beneficial actions of non-steroidal anti-inflammatory drugs to flavonoids. (2013) (30)
- Systemic effects of ingested nickel on the immune system of nickel sensitised women. (1999) (30)
- Mast cell, pro-inflammatory and anti-inflammatory: Jekyll and Hyde, the story continues. (2017) (30)
- IL-37 is increased in brains of children with autism spectrum disorder and inhibits human microglia stimulated by neurotensin (2019) (30)
- Brain inflammation, neuropsychiatric disorders, and immunoendocrine effects of luteolin. (2014) (30)
- Effects of low frequency electromagnetic fields on expression of lymphocyte subsets and production of cytokines of men and women employed in a museum. (2001) (30)
- Critical role of inflammatory mast cell in fibrosis: Potential therapeutic effect of IL‐37 (2018) (29)
- IL-1 Superfamily Members and Periodontal Diseases (2020) (29)
- Blocking the interleukin-1 receptor inhibits leukotriene B4 and prostaglandin E2 generation in human monocyte cultures. (1992) (28)
- Stimulation of CCL2 (MCP-1) and CCL2 mRNA by substance P in LAD2 human mast cells. (2009) (28)
- RANTES is a pro‐inflammatory chemokine and chemoattracts basophil cells to extravascular sites (1997) (28)
- IL-4 in vitro production is upregulated in Alzheimer's disease patients treated with acetylcholinesterase inhibitors (2004) (28)
- Inhibition of interleukin-1 beta mRNA expression and interleukin-1 alpha and beta secretion by a specific human recombinant interleukin-1 receptor antagonist in human peripheral blood mononuclear cells. (1992) (27)
- Associations between hypertriglyceridemia and serum ghrelin, adiponectin, and IL-18 levels in HIV-infected patients. (2006) (27)
- Synergistic activation of serum amyloid A (SAA) by IL-6 and IL-1 in combination on human Hep 3B hepatoma cell line. Role of PGE2 and IL-1 receptor antagonist. (1995) (27)
- Recombinant interleukin 1 and tumor necrosis factor acting in synergy to release thromboxane, 6-KETO-PGF1 alpha and PGE2 by human neutrophils. (1988) (26)
- Effect of interleukin-1 receptor antagonist on vascular smooth muscle cell proliferation. (1993) (26)
- Mast Cells May Regulate The Anti-Inflammatory Activity of IL-37 (2019) (26)
- Mast Cell Serotonin Immunoregulatory Effects Impacting on Neuronal Function: Implications for Neurodegenerative and Psychiatric Disorders (2015) (26)
- Mast Cell Cytokines IL-1, IL-33, and IL-36 Mediate Skin Inflammation in Psoriasis: A Novel Therapeutic Approach with the Anti-Inflammatory Cytokines IL-37, IL-38, and IL-1Ra (2021) (25)
- Mast cells emerge as mediators of atherosclerosis: Special emphasis on IL-37 inhibition. (2017) (25)
- Sodium chromo-glycate and palmitoylethanolamide: A possible strategy to treat mast cell-induced lung inflammation in COVID-19 (2020) (24)
- Interferon β-1b modulates MCP-1 expression and production in relapsing–remitting multiple sclerosis (2002) (24)
- Down‐regulation of cyclooxygenase‐2 (COX‐2) by interleukin‐1 receptor antagonist in human monocytes (1996) (24)
- Impact of polyphenols on mast cells with special emphasis on the effect of quercetin and luteolin (2018) (24)
- Inhibition of Interleukin‐1 (Alpha and Beta), Interleukin‐2 Secretion and Surface Expression of Interleukin‐2 Receptor (IL‐2R) by a Novel Cytokine Interleukin‐1 Receptor Antagonist (IL‐lra) (1992) (24)
- Endothelial Cells, Cholesterol, Cytokines, and Aging (2012) (24)
- Mast cell involvement in rheumatoid arthritis. (2013) (23)
- Activation and inhibition of adaptive immune response mediated by mast cells. (2017) (23)
- Mechanism by Which Il-16 Generated by Mast Cells Mediates Allergic Inflammation (2001) (23)
- Impact of IL -9 and IL-33 in mast cells. (2012) (22)
- Is Necroptosis a Death Pathway in Aluminum-Induced Neuroblastoma Cell Demise? (2008) (22)
- Impact of mast cells in systemic lupus erythematosus: can inflammation be inhibited? (2019) (22)
- Impact and Neuropeptide Substance Pan Inflammatory Compound on Arachidonic Acid Compound Generation (2012) (21)
- Inflammatory cytokines and S-100b protein in patients with hepatitis C infection and cryoglobulinemias. (2007) (21)
- MK-954 (losartan potassium) exerts endothelial protective effects against reperfusion injury: evidence of an e-NOS mRNA overexpression after global ischemia. (2001) (21)
- Interrelationship between inflammatory cytokines (IL-1, IL-6, IL-33, IL-37) and acquired immunity. (2019) (21)
- Interleukin-9 and mast cells. (2012) (21)
- IL-36 Receptor Antagonist with Special Emphasis on IL-38 (2013) (21)
- Involvement of NK cells against tumors and parasites. (2007) (21)
- Modulation of rat vascular smooth muscle cell (VSMC) proliferation by cysteinyl leukotriene D4: a role for mediation of interleukin 1. (1995) (21)
- IL-36 a new member of the IL-1 family cytokines. (2012) (20)
- Impact of mast cells in mucosal immunity of intestinal inflammation: Inhibitory effect of IL‐37 (2018) (20)
- How Do Rat Cortical Cells Cultured with Aluminum Die: Necrosis or Apoptosis? (2008) (20)
- Relevance of plant lectins in human cell biology and immunology. (2006) (20)
- IL-38 inhibits microglial inflammatory mediators and is decreased in amygdala of children with autism spectrum disorder (2020) (19)
- Interleukin-19 (IL-19) Network Revisited (2003) (19)
- Interleukin 27 (IL-27): A Novel Pleiotropic Cytokine Involved in T Cell Differentiation and T Cell Response Modulation (2005) (19)
- A case of obsessive-compulsive disorder successfully treated with agomelatine monotherapy. (2012) (19)
- CAR-T cell therapy causes inflammation by IL-1 which activates inflammatory cytokine mast cells: anti-inflammatory role of IL-37. (2019) (19)
- Impact of mast cells in fibromyalgia and low‐grade chronic inflammation: Can IL‐37 play a role? (2019) (18)
- Massive infiltration of basophilic cells in inflamed tissue after injection of RANTES. (1997) (18)
- IL-37 a New IL-1 Family Member Emerges as a Key Suppressor of Asthma Mediated by Mast Cells (2017) (18)
- Link between mast cells and bacteria: Antimicrobial defense, function and regulation by cytokines. (2017) (18)
- Monocyte chemotactic protein-1 is a proinflammatory chemokine in rat skin injection sites and chemoattracts basophilic granular cells. (1997) (18)
- Effect of the Compound L-Mimosine in an in Vivo Model of Chronic Granuloma Formation Induced by Potassium Permanganate (KMNO4) (2003) (17)
- Interleukin-17: A Revisited Study (2004) (17)
- Mast cell in innate immunity mediated by proinflammatory and antiinflammatory IL-1 family members. (2017) (17)
- Inhibition of MCP-1 and MIP-2 Chemokines in Murine Trichinellosis: Effect of the Anti-Inflammatory Compound L-Mimosine (2005) (17)
- Induction of monocyte chemotactic protein-1 (MCP-1) and TNF alpha by Trichinella spiralis in serum of mice in vivo (1998) (17)
- Chemokines as Markers for Parasite-Induced Inflammation and Tumors (2005) (17)
- Activated Mast Cells Mediate Low-Grade Inflammation in Type 2 Diabetes: Interleukin-37 Could Be Beneficial. (2018) (16)
- A new pharmacological approach based on remdesivir aerosolized administration on SARS-CoV-2 pulmonary inflammation: A possible and rational therapeutic application☆☆☆ (2020) (16)
- The G51S purine nucleoside phosphorylase polymorphism is associated with cognitive decline in Alzheimer's disease patients (2007) (16)
- Human recombinant IL‐1 receptor antagonist (IL‐IRa) inhibits leukotriene B4 generation from human monocyte suspensions stimulated by lipopolysaccharide (LPS) (1993) (16)
- Response of spinal myoclonus to a combination therapy of autogenic training and biofeedback (2007) (16)
- Transcription and translation of the chemokines RANTES and MCP-1 in nasal polyps and mucosa in allergic and non-allergic rhinopathies. (2003) (16)
- Human recombinant interleukin‐1 receptor antagonist inhibits lymphocyte blastogenesis induced by concanavalin A Restorative effect of hrIL‐1 (1991) (15)
- Inhibition of MCP-1 and MIP-2 transcription and translation by mimosine in muscle tissue infected with the parasite Trichinella spiralis (2004) (15)
- New aspect of allergic contact dermatitis, an inflammatory skin disorder mediated by mast cells: Can IL-38 help? (2020) (15)
- Advances in Mast Cell Activation by IL-1 and IL-33 in Sjögren’s Syndrome: Promising Inhibitory Effect of IL-37 (2020) (15)
- Interleukin-25 (OR IL-17E): A New IL-17 Family Member with Growth Factor/Inflammatory Actions (2003) (15)
- Neuropeptide substance P induces mRNA expression and secretion of CXCL8 chemokine, and HDC in human umbilical cord blood mast cells. (2008) (15)
- In vitro effects of vanadate on human immune functions. (2002) (15)
- Interleukin-1 (IL-1) and interleukin-1 receptor antagonist (IL-1ra). (1991) (15)
- The combination of interleukin 1 plus tumor necrosis factor causes greater generation of LTB4, thromboxanes and aggregation on human macrophages than these compounds alone. (1989) (14)
- Role of lipoxins A4 and B4 in the generation of arachidonic acid metabolites by rat mast cells and their effect on [3H]serotonin release. (1992) (14)
- Periodontitis and cytokine patterns in HIV positive patients. (2008) (14)
- Impact of extremely low frequency electromagnetic fields on CD4 expression in peripheral blood mononuclear cells (1999) (14)
- Bacillus Calmette-Guérin potentiates monocyte responses to lipopolysaccharide-induced tumor necrosis factor and interleukin-1, but not interleukin-6 in bladder cancer patients (1994) (14)
- Impact of mast cells in depression disorder: inhibitory effect of IL-37 (new frontiers) (2018) (14)
- Elevated Circulating Levels of Monocyte Chemoattractant Protein-1 in Patients With Restenosis After Coronary Angioplasty (2001) (13)
- Are mast cells important in diabetes? (2016) (13)
- Lipoxin A augments release of thromboxane from human polymorphonuclear leukocyte suspensions (1987) (13)
- Activation of mast cells mediates inflammatory response in psoriasis: Potential new therapeutic approach with IL‐37 (2019) (13)
- Inhibitory Effect of Quercetin on Tryptase and MCP-1 Chemokine Release, and Histidine Decarboxylase mRNA Transcription by Human Mast Cell-1 Cell Line (2007) (13)
- Leukocyte inhibitory factor activates human neutrophils and macrophages to release leukotriene B4 and thromboxanes. (1990) (13)
- Powerful anti‐inflammatory action of luteolin: Potential increase with IL‐38 (2021) (13)
- Neuroendocrine Immunophenotype as Predictor of Clinical Recurrence in 110 Patients with Prostate Cancer (2007) (12)
- Reduced mitogen stimulation of DNA synthesis in human lymphocytes by a human recombinant interleukin-1 receptor antagonist. (1991) (12)
- Interferon beta-1b modulates MCP-1 expression and production in relapsing-remitting multiple sclerosis. (2002) (12)
- Rantes potentiates human macrophage aggregation and activation responses to calcium ionophore (A23187) and activates arachidonic acid pathways. (2006) (12)
- Cytokines and Allergic Disorders: Revisited Study (2004) (11)
- Infections and mast cells. (2009) (11)
- EFFECTS OF MELANOPROTEINS AND THEIR PRECURSORS ON CELL PROLIFERATION THE PROBLEM OF SELECTIVITY (1979) (11)
- Expression of lymphocyte subpopulations, cytokine serum levels and blood and urine trace elements in nickel sensitised women. (1998) (11)
- Mast cells participate in allograft rejection: can IL-37 play an inhibitory role? (2018) (11)
- Restoration of anti-interleukin-1 depressed natural killer activity by human recombinant interferon α or γ, human recombinant interleukin-2 and indomethacin (1988) (11)
- Inhibition of granuloma formation induced by potassium permanganate in the mouse by a specific human recombinant receptor antagonist for interleukin-1 (hrIL-1ra). (1993) (11)
- Impact of Fungi on Immune Responses. (2018) (11)
- Substance P Upregulates LTB4 in Rat Adherent Macrophages from Granuloma Induced by KMnO4 (2009) (11)
- Allergen Immunotherapy: An Effective Immune-modifier (1999) (10)
- Oxygen supply modulates MCP-1 release in monocytes from young and aged rats: Decrease of MCP-1 transcription and translation is age-related (2003) (10)
- Differential expression and secretion of RANTES and MCP-1 in activated peripheral blood mononuclear cell cultures of atopic subjects. (2001) (10)
- Mesenchymal stem cells and IL-37: a powerful combination. (2019) (10)
- Different signals induce mast cell inflammatory activity: inhibitory effect of Vitamin E. (2018) (10)
- Effect of electromagnetic fields on several CD markers and transcription and expression of CD4. (1999) (10)
- Inflammatory Markers: Serum Amyloid A, Fibrinogen and C-Reactive Protein — A Revisited Study (2011) (10)
- Cysteinyl-leukotriene D4 induced IL-1 beta expression and release in rat vascular smooth muscle cells. (1995) (10)
- IgG, IgG1 and IgM response in Trichinella spiralis-infected mice treated with 4-deoxypirydoxine or fed a Vitamin B6-deficient diet (1999) (9)
- Lipoxins A4 and B4 inhibit leukotriene B4 generation from human neutrophil leukocyte suspensions. (1990) (9)
- Reduced human lymphocyte blastogenesis and enhancement of adenosine triphosphate (ATP) by L-carnitine (1994) (9)
- Will MCP-1 and RANTES take center stage in inflammatory diseases including asthma? (1998) (9)
- Potential therapeutic use of IL-37: a key suppressor of innate immunity and allergic immune responses mediated by mast cells (2017) (9)
- Activation of lymphocytes by H2O2(1). (1980) (9)
- IL-34 a Newly Discovered Cytokine (2010) (9)
- MCP-1 and MIP-2 levels during Echinococcus granulosus infections in mice (2001) (9)
- Localization and activity of iNOS in normal human lung tissue and lung cancer tissue. (2007) (9)
- Relationship between Vitamin C, Mast Cells and Inflammation (2016) (9)
- Augmentation of monocyte chemotactic protein‐1 and mRNA transcript in chronic inflammatory states induced by potassium permanganate (KMnO4) in vivo (1997) (9)
- TT Virus Infection: Role of Interferons, Interleukin-28 and 29, Cytokines and Antiviral Proteins (2007) (9)
- Expression and secretion of RANTES by human peripheral blood CD4+ cells are dependent on the presence of monocytes. (2001) (9)
- MCP-1 and MIP-2 response in Trichinella spiralis infected mice treated with 4-deoxypyridoxine (4-DPD). (2002) (8)
- Antibodies for COVID-19 - which, when and how long? (2021) (8)
- IL-1β Induces Alkaline Phosphatase in Human Phagocytes (2007) (8)
- A COMPARATIVE STUDY OF BIPOLAR DISORDER AND ATTENTION DEFICIT HYPERACTIVITY DISORDER THROUGH THE MEASUREMENT OF REGIONAL CEREBRAL BLOOD FLOW (2012) (8)
- Evidence of hepatitis C virus-specific interferon gamma-positive T cells in health care workers in an infectious disease department. (2009) (8)
- Simvastatin reduces postischemic coronary dysfunction: ultrastructural and functional findings after acute administration. (2000) (8)
- Human recombinant interleukin-1β induces thromboxane A2 release in polymorphonuclear leukocytes, macrophages and platelets: Effect of IL-1 receptor antagonist (1996) (8)
- Increase in CD45RO+ cells and activated eosinophils in chronic allergic conjunctivitis. (2000) (7)
- Recent insights in primary immunodeficiency diseases: the role of T-lymphocytes and innate immunity. (2010) (7)
- Immunological activation of human umbilical cord blood mast cells induces tryptase secretion and interleukin-6, and histidine decarboxilase mRNA gene expression. (2007) (7)
- Inhibition of leukotriene B4 in neutrophils by lipoxins A4 and B4 (2005) (7)
- The down-regulation of IL-6-stimulated fibrinogen steady state mRNA and protein levels by human recombinant IL-1 is not PGE2-dependent: Effects of IL-1 receptor antagonist (IL-1RA) (1995) (7)
- Enhancing Effect of Electromagnetic Exposure on Calciumionophore (A23187), but Not IL-1, Induced Txa2 Release by Human Neutrophils (1991) (7)
- A Scavenger Role for Nitric Oxide in the Aged Rat Kidney (2004) (7)
- 4-Deoxypyridoxine inhibits chronic granuloma formation induced by potassium permanganatein vivo (1994) (6)
- Granulocyte-macrophage colony stimulating factor potentiates human polymorphonuclear leukocyte aggregation responses to formyl-methionyl-leucyl-phenylalanine. (1992) (6)
- IL-1beta induces alkaline phosphatase in human phagocytes. (2007) (6)
- Effect of extremely low frequency electromagnetic fields on thromboxane B2-release by ionophore-stimulated neutrophils in vitro (1984) (6)
- RANTES (CCL5) potentiates calcium ionophore in the production of LTB4 in rat adherent macrophages from granuloma induced by KMnO4: inhibiton by NDGA. (2008) (6)
- Autophagy processes are dependent on EGF receptor signaling (2018) (6)
- Expression of Co-stimulatory Molecules on Langerhans Cells in Lesional Epidermis of Human Atopic Dermatitis (2007) (5)
- Effect of salicylates on lymphocyte blastogenesis in vitro: Association with other non-steroid anti-inflammatory drugs (1983) (5)
- Inhibitor Effect of Antioxidant Flavonoids Quercitin, and Capsaicin in Mast Cell Inflammation (2013) (5)
- Generation of TNFα, IFNγ, IL-4, IL-6 and IL-10 in Trichinella spiralis infected mice: effect of the anti-inflammatory compound mimosine (2001) (5)
- Comparison of Serum Total Valproic Acid Levels and %CDT Values in Chronic Alcohol Addictive Patients in an Italian Clinic: A Retrospective Study (2016) (5)
- Impact of Cytokines in Mast cells Allergic Inflammation (2013) (5)
- Leukocyte inhibitory factor (LIF) potentiates human macrophage aggregation and activation responses to calcium ionophore A23187 and directly induces leukotriene B4 and thromboxane A2 release. (1993) (5)
- CD4+/CD25+ T cells suppress autologous CD4+/CD25- lymphocytes and secrete granzyme B during acute and chronic hepatitis C. (2014) (5)
- Expression and Secretion of RANTES (CCL5) in Granulomatous Calcified Tissue before and after Lipopolysaccharide Treatment In Vivo (2006) (4)
- Lipoxins increase granuloma formation induced by potassium permanganatein vivo (2005) (4)
- Calcium content of experimental granuloma as determined by X-ray fluorescence. Influence of non-steroid anti-inflammatory drugs (1980) (4)
- Expression and Secretion of CXCL8 (IL-8), Release of Tryptase and Transcription of Histidine Decarboxylase mRNA by Anti-IgE-Activated Human Umbilical Cord Blood-Derived Cultured Mast Cells (2007) (4)
- Induction of CCL2 (MCP-1) BY IL-33 in Human Umbelical Cord Blood Mast Cells (2012) (4)
- Recent progress on pathophysiology, inflammation and defense mechanism of mast cells against invading microbes: inhibitory effect of IL-37 (2020) (4)
- Interleukin-1 receptor antagonist inhibits calcium accumulation in in vivo chronic granuloma induced by potassium permanganate (1993) (4)
- Impact of Mast Cells in Rejection of Allografts (2013) (4)
- Effect of the antirheumatic agent Tenidap on CD3, CD4, and CD8 expression and interleukin-1 and leukotriene B4 secretion in human peripheral blood mononuclear cells. (1994) (4)
- Increase of granzyme B‐positive cells in ascitic fluid of patients with spontaneous bacterial peritonitis (2008) (4)
- Letter to Editor: Chemokine Network Involved in Inflammatory Skin Diseases. (2015) (4)
- Brief Review: Advances in Therapy with Antileukotriene Drugs (2004) (4)
- “In Vitro” Comparative Immune Effects of Different Titanium Compounds (2004) (4)
- Stimulatory effect of hr tumor necrosis factor on TxB2 release by polymorphonuclears and macrophages (1986) (3)
- Influence of Interleukin‐1 Receptor Antagonist on [3H] Serotonin and Histamine Release by Rat Basophilic Leukemia‐2H3 Cells (1997) (3)
- CD 25 high T cells with a prolonged survival inhibit development of diabetes (2009) (3)
- Impact of Vitamin D on Mast Cell Activity, Immunity and Inflammation (2016) (3)
- Mast Cells Mediate Skin Inflammation in Psoriasis: A Novel Therapeutic Approach with the Anti-inflammatory Cytokines IL-37, IL-38 and IL-1Ra (2021) (3)
- Mast Cells to Dendritic Cells: Let IL-13 Shut Your IL-12 Down. (2021) (3)
- Human recombinant interleukin-1 receptor antagonist (hrIL-1RA) inhibits prostaglandin E2 (PGE2) generation but not alkaline phosphatase activity in in vivo chronic granulomatous tissue induced by KMnO4. (1993) (3)
- Induction of alkaline phosphatase generation by il-1β and LPS on human neutrophils and macrophages and lack of inhibition by interleukin-1 receptor antagonist (1995) (3)
- Impact of IL-33 on PGD2 Generation by Activated Human Cord Blood-Derived Mast Cell: Lack of Effect on Tryptase Release (2012) (3)
- Calcium Ionophore A23187 and Compound 48/80 Induce PGD2 and Tryptase in Human Cord Blood-Derived Mast Cells: Lack of Effect of IL-18 (2012) (3)
- Epileptic EEG discharges and short non-convulsive crisis: Influence on cognitive and psychobehavioural functions in youths. (2008) (3)
- Review : Role of Mast Cells in Tumor Growth (2007) (3)
- Differential TBXA2 receptor transcript stability is dependent on the C924T polymorphism. (2017) (3)
- Letter to the editor: Macrophage down‐regulation by interleukin‐1 receptor antagonist (1992) (2)
- A comparative study of the effects of some non-steroidal anti-inflammatory drugs on prostacyclin productionex vivo and on thromboxane B2 release by polymorphonuclearsin vitro (1984) (2)
- Rat basophilic leukemia cells (RBL-2H3) generate prostaglandin D2 (PGD2) after regulated upon activation, normal T-cell expressed and secreted (RANTES) activation. (2006) (2)
- The anti-inflammatory actions of azelastine. (2002) (2)
- Effect of indomethacin or aspirin in association with diflunisal or sodium salicylate on prostacyclin release by rat gastric mucosa (1983) (2)
- Effect of supernatants from PHA-stimulated and non-stimulated lymphocyte cultures on thromboxane B2 release by polymorphonuclear leukocytesin vitro (1985) (2)
- Effect of hrTNF alpha on TxB2 release by macrophages. (1987) (2)
- Rat peritoneal mast cells release regulated upon activation normal T cell expressed and secreted (RANTES) after TNF-alpha activation. (2005) (2)
- Vitamin B6-deficient diet plus 4-deoxypyridoxine (4-DPD) reduces the inflammatory response induced by T. spiralis in diaphragm, masseter and heart muscle tissue of mice (1999) (2)
- New insight into systemic mastocytosis mediated by cytokines IL-1β and IL-33: Potential inhibitory effect of IL-37. (2019) (2)
- What You Should Know about Escherichia Coli Infection (2011) (2)
- Role of flavonoids and vitamins in cancer. (2007) (2)
- Enhanced thromboxane synthesis and vacuolization in human polymorphonuclear leucocytes induced by human lymphokine containing supernatants (1985) (2)
- Augmentation of thromboxane productionin vitro by polymorphonuclears and macrophages exposed to IL1/LP (2005) (2)
- Effect of interleukin-1 receptor antagonist (IL-1RA) on histamine and serotonin release by rat basophilic leukemia cells (RBL-2H3) and peritoneal mast cells (1996) (2)
- Macrophage down-regulation by interleukin-1 receptor antagonist. (1992) (2)
- Human recombinant interleukin-1 receptor antagonist (hrIL-1ra) enhances the stimulatory effect of interleukin-2 on natural killer cell activity against MOLT-4 target cells. (1992) (1)
- Inhibition of LTB4 monocyte production by interleukin-1 receptor antagonist (IL-1RA) (1991) (1)
- [Effect of the association of caffeine-indomethacin on the production of prostacyclin in the rat stomach]. (1982) (1)
- A CONTEMPORARY UPDATE ON PATHOLOGY REPORTING FOR URINARY BLADDER CANCER (2013) (1)
- Possible role of mast cells and IL-37 in the pathogenesis of psoriasis (2017) (1)
- RANTES and MCP-1 secretion by mononuclear cells of patients with multiple sclerosis (1998) (1)
- Infra-red laser irradiation enhances interleukin-1 receptor antagonist, increases 3H-thymidine incorporation and the release of [3H]arachidonic acid in human monocytes (1997) (1)
- Heme Oxigenase-1 (HO-1) and Oxidative Stress in Rat Heart (2003) (1)
- PREVALENCE OF IL-1 β + 3954 AND IL-1 α-889 POLYMORPHISMS IN THE LEBANESE POPULATION AND ITS ASSOCIATION WITH THE SEVERITY OF ADULT CHRONIC PERIODONTITIS (2013) (1)
- Role of TNF Alpha, IL-33 and CCL2/MCP-1 in Mast Cell Activity (2013) (1)
- IgE and macrophages for cancer rescue? (2019) (1)
- Restoration of anti-interleukin-1 depressed natural killer activity by human recombinant interferon alpha or gamma, human recombinant interleukin-2 and indomethacin. (1988) (1)
- Inhibition of leukotriene B4(LTB4) by recombinant interleukin-1 receptor antagonist (IL-1RA) on human monocytes (2005) (1)
- Mast Cells Mediate Rheumatoid Arthritis-Inhibitory Role of IL-37. (2019) (1)
- Localization and Activity of iNOS in Normal Human Lung Tissue and Lung Cancer Tissue (2007) (1)
- Synergistic activation of natural killer activity by human recombinant interferon alpha or gamma and indomethacin (1986) (1)
- Analytical Management of Patients Undergoing Oral Anticoagulant Therapy Could Have a Strong Impact on Clinical Outcomes: A Follow-up Study (2017) (1)
- Monocyte Chemotactic Protein-1 Gene Expression and Translation in Formed Granulomatous Calcified Tissue In Vivo (2014) (1)
- ROLE OF MACROPHAGE IN TUMOR MICROENVIRONMENT : PROSPECT IN CANCER IMMUNOTHERAPY (2013) (1)
- SEROTONIN RECEPTOR GENE ( 5-HTR 3 A ) EXPRESSION CHANGES ON HUMAN PERIPHERAL BLOOD LYMPHOCYTES IN RHEUMATOID ARTHRITIS (1)
- Detection of nuclear and membrane antigens by liquid-based cytology following long-term storage of d1 cells, karpas cells, and peripheral blood mononuclear cells. (2011) (0)
- [Inhibition of prostaglandins in experimental inflammation after treatment with a new non-steroidal anti-inflammatory drug MK647]. (1978) (0)
- Mast Cell Cytokines in Acute and Chronic Gingival Tissue Inflammation: Role of IL-33 and IL-37 (2022) (0)
- Effects Induced “in vitro” by Extremely Low Frequency Electromagnetic Fields (E.L.F.) on Blastogenesis of Human Lymphocytes and on Thromboxane B-2-Release by Ionophore-Stimulated Neutrophils (1985) (0)
- EFFECTIVE PROPERTIES OF A STURGEON-BASED BIOACTIVE COMPOUND ON STRESS-INDUCED HIPPOCAMPAL DEGENERATION AND ON IN VITRO NEUROGENESIS (2013) (0)
- Salute to Our Reviewers. (2016) (0)
- Reply to Fattori et al.: Action of SP and IL-33 on mast cells (2017) (0)
- Comparative effects of indomethacin and proglumetacin on 6-oxo-PGF1 alpha released ex vivo by rat gastric mucosa. (1986) (0)
- Augmentation ofmonocytechemotactic protein-i andmRNA transcript inchronic inflammatory states induced bypotassium permanganate (KMnO4)invivo (1997) (0)
- Fourth European Workshop on Inflammation Wilrijk March 1982 (1982) (0)
- Dielectric Spectroscopy of Human Lymphocytes Exposed to a 3Hz Pulsed Magnetic field (1995) (0)
- Effect of IL-1 and its inhibitor on arachidonic acid cascade (1991) (0)
- Potential therapeutic use of IL-37: a key suppressor of innate immunity and allergic immune responses mediated by mast cells (2017) (0)
- [E-N-trimethyl-lysine: a natural cellular component with mitogenic activity]. (1980) (0)
- Impact of mast cells in depression disorder: inhibitory effect of IL-37 (new frontiers) (2018) (0)
- Involvement of NK Cells against Tumors and Parasites (2007) (0)
- Impact of vitamin D on asthma (2016) (0)
- Inhibition of leukotriene B4(LTB4) by recombinant interleukin-1 receptor antagonist (IL-1RA) on human monocytes (2005) (0)
- [The behavior of lymphocyte cultures irradiated by radioisotope sources at low doses and stimulated by PHA]. (1977) (0)
- [Calcium content of KMnO4 induced granuloma after treatment with 2 combined non-steroidal drugs: indomethacin plus diflunisal]. (1980) (0)
- Mast cells participate in allograft rejection: can IL-37 play an inhibitory role? (2018) (0)
- [Effects of submaxillary gland removal on the gonads in male mice]. (1978) (0)
- [In vitro study on the sensitivity of various bacteria to a new antibiotic resistant to beta-lactamases]. (1978) (0)
- Comparison of Serum Total Valproic Acid Levels and %CDT Values in Chronic Alcohol Addictive Patients in an Italian Clinic: A Retrospective Study. (2016) (0)
- [The influence of levamisole in vitro on lymphocytes from an immunodeficient patient]. (1980) (0)
- Anemia di Blackfan Diamond: Registro Italiano AIEOP (2016) (0)
- Author ' s personal copy Novel therapeutic targets for autism (2008) (0)
- [Preliminary studies of the action of dexamethasone and diflunisal in experimental inflammation]. (1978) (0)
- Erratum in Int J Biol Markers 2007; 22(3): 226-231. (2007) (0)
- [Effect of calcium ionophore (A23187) on the production of thromboxane B2 in human polymorphonuclear cells in vitro]. (1984) (0)
- Inhibition of Prostaglandin E2 (PGE2) by Human Recombinant Interleukin-1 Receptor Antagonist (hrIL-1ra) (1993) (0)
- [Positivity differences in detection of Australia antigen (HB-Ag) in a population sample examined with the radioimmunologic method and the "hepanosticon" method]. (1978) (0)
- Enhanced natural killer cell activity by proglumetacin, a non-steroidal anti-inflammatory drug (2005) (0)
- Monoclonal antibody therapy in COVID-19 induced by SARS-CoV-2. (2021) (0)
- L-CARNITINE ENHANCES ADENOSINE TRIPHOSPHATE (ATP) AND INHIBITS LYMPHOCYTE PROLIFERATION (1995) (0)
- Protein and mRNA Levels for Histidine Decarboxylase Recruitment in Rat Skin Injection Model and Their Role in Modifying the Impact of Rantes and MCP-1 Chemokines on In Vivo Basophilic Cell (2010) (0)
- [Action of some salicylates associated with other non-steroidal anti-inflammatory drugs on the release of prostacyclin from the gastric mucosa of the rat]. (1982) (0)
- [Experience with a new method of study of lymphocyte blast formation: preliminary results]. (1978) (0)
- In fl ammatory cytokines and S-100 b protein in patients with hepatitis C infection and cryoglobulinemia (2007) (0)
- Rat Basophilic Leukemia Cells (RBL-2H3) Generate Prostaglandin D2 (PGD2) after Regulated upon Activation, Normal T-cell Expressed and Secreted (RANTES) activation (2006) (0)
- ["Granuloma pouch" reduction after treatment with indomethacin and diflunisal and collateral effects of these drugs on gastric mucosa]. (1980) (0)
- [Reduced ulcerogenic effect after treatment with indomethacin combined with diflunisal in rats]. (1980) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Pio Conti?
Pio Conti is affiliated with the following schools:
